PET‐CT versus MRI in the diagnosis of lymph node metastasis of cervical cancer: A meta‐analysis
Authors:
- 4 January 2022
- journal article
- research article
- Published by Wiley in Microscopy Research and Technique
- Vol. 85 (5) , 1791-1798
Abstract
To compare the clinical application value of positron emission tomography–computed tomography (PET‐CT) and magnetic resonance imaging (MRI) in the diagnosis of cervical cancer lymph node metastasis. We searched PubMed and other databases for the studies comparing the use of PET‐CT and MRI for the diagnosis of cervical cancer lymph node metastasis up to January 20, 2021. We strictly followed the inclusion and exclusion criteria to screen the literature and extract the data. Quality Assessment of Diagnostic Accuracy Studies (QUADAS)‐2 tool was used for quality evaluation of included studies, and Revman 5.3 and Stata 15.0 software were used for evaluating heterogeneity, synthesize sensitivity (SEN), specificity (SPE), positive likelihood ratio, negative likelihood ratio, diagnostic odds ratio (DOR), and the area under the curve (AUC) and comparing the pretest and posttest probabilities. Finally, 11 studies were included for meta‐analysis. The synthesized results indicated that the SEN value of PET‐CT was 0.65 (0.60 ~ 0.69) and SPE was 0.93 (0.91 ~ 0.94), and the SEN value of MRI was 0.58 (0.54 ~ 0.63) and SPE was 0.91 (0.90 ~ 0.92). AUC of PET‐CT was 0.824, which was significantly higher than that of MRI (AUC = 0.702; p < .05). The subgroup analysis showed that the AUC value of the study based on study design and use of blinding methods was not statistically significant (all p > .05). There was no obvious publication bias in the synthesized analysis of the diagnostic value of PET‐CT and MRI (all p > .05).Highlights: To compare positron emission tomography–computed tomography (PET‐CT) and magnetic resonance imaging (MRI) in diagnosis of cervical cancer lymph node metastasis. Synthesize sensitivity value of PET‐CT was comparable with that of MRI. Area under the curve of PET‐CT was significantly higher than that of MRI. There was no obvious publication bias in synthesized analysis.Keywords
This publication has 40 references indexed in Scilit:
- Magnetic resonance imaging after external beam radiotherapy and concurrent chemotherapy for locally advanced cervical cancer helps to identify patients at risk of recurrenceInternational Journal of Gynecological Cancer, 2019
- Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questionsGynecologic Oncology, 2019
- Progress in the Study of Lymph Node Metastasis in Early-stage Cervical CancerCurrent Medical Science, 2018
- Value of imaging study in predicting pelvic lymph node metastases of uterine cervical cancerRadiation Oncology Journal, 2017
- Comparison of positron emission tomography/computed tomography and magnetic resonance imaging for posttherapy evaluation in patients with advanced cervical cancer receiving definitive concurrent chemoradiotherapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2017
- Role of 18F-FDG PET/CT in detecting pelvic lymph-node metastases in patients with early-stage uterine cervical cancerNuclear Medicine Communications, 2014
- Pretreatment Retroperitoneal Para-aortic Lymph Node Staging in Advanced Cervical Cancer A ReviewInternational Journal of Gynecological Cancer, 2014
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment?Cancer, 2011
- Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinomaCancer, 2006